Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Eczema-wise logo link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Clinical Trials for Eczema (Atopic Dermatitis)

PEER Services

Clinical Trials Logo

The icon above indicates a trial that has been approved for premier listing status.

If you are a clinic or a researcher who would like to apply for premier listing status, or learn more about NEA’s People Engaged in Eczema Research (PEER) services, please click here.

A clinical trial is a research study in human volunteers used to determine whether new drugs or treatments are safe and effective. Clinical testing is preceded by extensive laboratory research, and is normally done in five phases. Participants can help themselves and others by contributing to medical research.

 

The following information is presented as a service to those who might be interested in participating in clinical research trials studying atopic dermatitis/eczema. Please click on the title of the research study for more information. Please feel free to contact the NEA office for more information.

Search & Filters

By Location
By Status
By Phase
By Condition
By Intervention

Trial Postings

Showing results

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

    Condition:
  • Atopic Dermatitis

Not yet recruiting

  • Los Angeles, California
  • Oklahoma City, Oklahoma
  • Portland, Oregon
  • Dallas, Texas
  • San Antonio, Texas
  • Surrey, British Columbia
  • Montreal, Quebec

Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis

    Condition:
  • Atopic Dermatitis

Recruiting

  • Besançon

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

    Condition:
  • Pruritus
  • Atopic Dermatitis

Recruiting

  • Birmingham, Alabama
  • Los Angeles, California
  • Los Angeles, California
  • N Miami Beach, Florida
  • Orange Park, Florida
  • Tampa, Florida
  • Boise, Idaho
  • Normal, Illinois
  • Carmel, Indiana
  • St. Joseph, Missouri
  • Verona, New Jersey
  • Corning, New York
  • Chapel Hill, North Carolina
  • Winston-Salem, North Carolina
  • Portland, Oregon
  • Philadelphia, Pennsylvania
  • Philadelphia, Pennsylvania
  • Anderson, South Carolina
  • Charleston, South Carolina
  • North Charleston, South Carolina
  • Dallas, Texas
  • San Antonio, Texas

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

    Condition:
  • Atopic Dermatitis
  • Eczema
  • Chronic Pruritus

Recruiting

  • Miami, Florida
  • New York, New York
  • New York, New York
  • High Point, North Carolina
  • Wilmington, North Carolina
  • Pflugerville, Texas

Topical Steroid Formulation and Wet Wraps

    Condition:
  • Dermatitis, Atopic

Recruiting

  • Austin, Texas

Efficacy of the "Атопик Soothing Cream" in Children With Mild to Moderate Atopic Dermatitis

    Condition:
  • Atopic Dermatitis

Recruiting

  • Samara

A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists

    Condition:
  • Eczema
  • Dermatitis
  • Dermatitis, Atopic
  • Genetic Disease, Inborn
  • Hypersensitivity
  • Hypersensitivity, Immediate
  • Immune System Diseases
  • Skin Diseases
  • Skin Diseases, Eczematous
  • Skin Diseases, Genetic

Recruiting

  • New Haven, Connecticut

Black Tea Compresses for Facial Eczema and Perioral Dermatitis

    Condition:
  • Eczema, Dermatitis

Recruiting

  • Lübeck, Schleswig-Holstein

Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis

    Condition:
  • Pruritus
  • Atopic Dermatitis

Recruiting

  • Anniston, Alabama
  • Birmingham, Alabama
  • Hoover, Alabama
  • Glendale, Arizona
  • Cerritos, California
  • Fountain Valley, California
  • Los Angeles, California
  • Oceanside, California
  • San Diego, California
  • San Diego, California
  • San Francisco, California
  • Santa Monica, California
  • Denver, Colorado
  • Jacksonville, Florida
  • Miami, Florida
  • Miami, Florida
  • Pinellas Park, Florida
  • Tampa, Florida
  • Tampa, Florida
  • Atlanta, Georgia
  • Savannah, Georgia
  • New Albany, Indiana
  • Bardstown, Kentucky
  • Louisville, Kentucky
  • Boston, Massachusetts
  • Warren, Michigan
  • Saint Joseph, Missouri
  • Berlin, New Jersey
  • Forest Hills, New York
  • Rochester, New York
  • High Point, North Carolina
  • Shelby, North Carolina
  • Oklahoma City, Oklahoma
  • Johnston, Rhode Island
  • Spartanburg, South Carolina
  • Chattanooga, Tennessee
  • Austin, Texas
  • Houston, Texas
  • Pflugerville, Texas
  • Plano, Texas
  • San Antonio, Texas
  • Draper, Utah
  • Norfolk, Virginia
  • Richmond, Virginia
  • Richmond, Virginia

A Study to Evaluate the Safety and Efficacy of INCB018424 Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

    Condition:
  • Atopic Dermatitis

Recruiting

  • Birmingham, Alabama
  • Bryant, Arkansas
  • Encino, California
  • Los Angeles, California
  • Oceanside, California
  • Riverside, California
  • San Luis Obispo, California
  • Trumbull, Connecticut
  • New Albany, Indiana
  • Plainfield, Indiana
  • Louisville, Kentucky
  • Louisville, Kentucky
  • Beverly, Massachusetts
  • Boston, Massachusetts
  • Detroit, Michigan
  • Saint Louis, Missouri
  • Saint Louis, Missouri
  • Portsmouth, New Hampshire
  • Berlin, New Jersey
  • High Point, North Carolina
  • Raleigh, North Carolina
  • Bexley, Ohio
  • Cleveland, Ohio
  • Norman, Oklahoma
  • Philadelphia, Pennsylvania
  • Upper Saint Clair, Pennsylvania
  • Arlington, Texas
  • Austin, Texas
  • College Station, Texas
  • Houston, Texas
  • San Antonio, Texas
  • San Antonio, Texas
  • Webster, Texas
  • Webster, Texas
  • Charlottesville, Virginia
  • Calgary, Alberta
  • Surrey, British Columbia
  • Winnipeg, Manitoba
  • Ajax, Ontario
  • Barrie, Ontario
  • Markham, Ontario
  • Mississauga, Ontario
  • North Bay, Ontario
  • Oakville, Ontario
  • Ottawa, Ontario
  • Peterborough, Ontario
  • Richmond Hill, Ontario
  • Toronto, Ontario
  • Waterloo, Ontario
  • Windsor, Ontario
  • Windsor, Ontario
  • Saint-jerome, Quebec

Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

    Condition:
  • Atopic Disorders
  • Eczema, Atopic

Recruiting

  • Birmingham, Alabama
  • Fort Smith, Arkansas
  • Long Beach, California
  • Los Angeles, California
  • Oceanside, California
  • Orange, California
  • Santa Monica, California
  • Coral Gables, Florida
  • Minneapolis, Minnesota
  • Plymouth, Minnesota
  • Saint Joseph, Missouri
  • Windsor, New Jersey
  • Corning, New York
  • High Point, North Carolina
  • Tulsa, Oklahoma
  • Portland, Oregon
  • Greer, South Carolina
  • Bellaire, Texas
  • Fort Worth, Texas
  • San Antonio, Texas

Efficacy and Safety of Dupilumab in Patients ≥12 to <18 Years of Age, With Moderate-to-Severe Atopic Dermatitis

    Condition:
  • Moderate-to-Severe Atopic Dermatitis
  • Dermatitis, Dermatitis Atopic
  • Eczema, Skin Diseases, Skin
  • Diseases Genetic, Genetic
  • Diseases Inborn, Skin
  • Disease, Eczematous Skin
  • Hypersensitivity, Immediate
  • Hypersensitivity, Immune System Diseases
  • Dermatitis, Atopic

Recruiting

  • Bakersfield, California
  • Long Beach, California
  • Orange, California
  • Santa Rosa, California
  • Centennial, Colorado
  • Macon, Georgia
  • Sandy Springs, Georgia
  • Rockville, Maryland
  • Plymouth, Minnesota
  • Tulsa, Oklahoma
  • Portland, Oregon
  • Charleston, South Carolina
  • San Antonio, Texas

A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis

    Condition:
  • Atopic Dermatitis
  • Eczema

Not yet recruiting

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

    Condition:
  • Atopic Dermatitis

Recruiting

  • Leiden

Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin

    Condition:
  • Xerosis
  • Xerosis Cutis
  • Dry Skin; Eczema

Recruiting

  • Tucson, Arizona
  • Sacramento, California

National Eczema Association Clinical Research Trials Policy

The National Eczema Association (NEA) is committed to improving patients’ quality of life through research, education, and support. NEA does not provide medical advice to patients but provides information to help them better understand their health, diagnosed conditions and the current range of approaches related to eczema treatment, prevention and supportive care. NEA urges patients to consult with a qualified physician for diagnosis and treatment.

As part of the fulfillment of its mission, NEA provides information to its constituents regarding clinical research trial availability and participation. NEA does not recruit patients for clinical trials and NEA does not conduct clinical trials. Below is a notice for a research study that we thought might be of interest to you. NEA is providing this information as a service. NEA does not endorse the study, which is being conducted at locations and under protocols that are not monitored or reviewed by NEA. Accordingly, NEA cannot be held responsible for anything that may occur in connection with the study. NEA may be reimbursed by the sponsor of the study for costs incurred in connection with notifying NEA constituents of the availability of the study. Should you have any questions regarding the study, please contact the study sponsor.

NEA respects your privacy and does not release your private information to any outside individuals, companies or organizations. Please see complete NEA Clinical Trials Policy here.

About Our Database Sources

ClinicalTrials.gov is a registry of federally or privately supported clinical trials conducted in the United States and around the world.